cmyc
transcript
factor
regul
varieti
cellular
process
includ
activ
cyclin
dcdk
cyclindepend
kinas
warburg
effect
cancer
cell
metabol
cellular
mrnp
process
myc
express
deregul
wide
rang
human
cancer
therefor
therapeut
target
recent
found
rnabind
protein
human
antigen
r
inhibit
cmyc
express
recruit
mirna
risc
rna
mirnainduc
silenc
complex
cmyc
rais
possibl
develop
cmyc
inhibitor
target
associ
rnp
cyclin
cyclin
cyclin
cyclin
encod
human
cell
member
cyclin
protein
famili
protein
involv
regul
cell
cycl
progress
transit
phase
cmyc
shown
regul
transcript
gene
involv
cell
cycl
includ
cyclin
retinoblastoma
tumor
suppressor
protein
prb
one
best
known
substrat
activ
cyclin
complex
thu
phosphoryl
prb
common
downstream
effector
cyclin
cmyc
tumor
suppressor
protein
prb
dysregul
sever
major
cancer
prb
stabl
protein
phosphoryl
sever
cdk
downregul
activ
activ
prb
act
tumor
suppressor
inhibit
cell
cycl
progress
hypophosphoryl
activ
form
prb
sequest
transcript
factor
prb
inactiv
hyperphosphoryl
releas
permit
execut
cell
cycl
regulatori
function
therefor
hyperphosphoryl
prb
late
phase
enabl
activ
transcript
eg
cyclin
cytoplasm
activ
proliferationassoci
protein
ubiquit
express
phosphoryl
requir
normal
cell
cycl
progress
phase
coloc
ra
gtpaseactiv
proteinbind
protein
within
cytoplasm
rna
granul
associ
microtubul
complex
thought
regul
transport
translat
mrna
whose
protein
product
involv
prolifer
migrat
multipl
cell
type
carboxyltermin
region
select
bind
cmyc
cyclin
mrna
collect
cmyc
mrna
cyclin
mrna
complex
repres
functionspecif
rnp
complex
requir
import
cellular
event
natur
product
constitut
success
promis
resourc
drug
discoveri
elucid
cellular
target
therapeut
natur
product
contribut
identif
valuabl
novel
drug
target
futur
develop
also
guid
subsequ
molecular
pharmacolog
modeofact
studi
tylophorinerel
natur
compound
found
asclepiadacea
moracea
plant
famili
exhibit
multipl
biolog
activ
eg
anticanc
anticoronaviru
antiinflammatori
activ
tylophorin
compound
focu
drug
develop
therapeut
agent
sinc
wherea
tylocrebrin
fail
phase
clinic
trial
due
neurotox
although
sever
mode
action
anticanc
tylophorin
compound
report
direct
cellular
target
relat
pathway
remain
elucid
particular
fundament
mechan
underli
broad
spectrum
drugresist
cancer
cell
inhibitori
activ
tylophorin
compound
remain
investig
design
synthes
biotinyl
tylophorin
compound
retain
molecular
target
moieti
enabl
probe
direct
cellular
target
combin
proteom
approach
molecular
mechan
studi
anticanc
activ
tylophorin
compound
elucid
result
provid
mechanist
basi
develop
tylophorin
deriv
compound
anticanc
drug
identifi
cellular
target
tylophorin
repres
novel
drug
target
anticanc
therapeut
applic
previous
report
nonplanar
structur
two
major
phenanthren
indolizidinequinolizidin
moieti
well
planar
rigid
indolizidinequinolizidin
moieti
tylophorin
compound
significantli
affect
activ
tylophorin
analogu
recent
success
synthes
potent
tylophorinederiv
dibenzoquinolin
elicit
biolog
function
tradit
pentacycl
tylophorin
compound
therefor
conclud
angular
dibenzoquinolin
moieti
tylophorin
compound
respons
interact
direct
target
molecul
thu
sought
design
synthes
biotinyl
tylophorinederiv
dibenzoquinolin
fig
refer
herein
biotinyl
tylophorin
probe
direct
interact
molecul
cell
biotinyl
tylophorin
retain
anticanc
cell
activ
valu
carcinoma
cell
see
supplement
tabl
cell
lysat
incub
vehicl
control
dimethyl
sulfoxid
dmso
biotinxss
biotinyl
tylophorin
prior
addit
streptavidin
pulldown
experi
pulleddown
complex
subject
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
silver
stain
analyz
protein
specif
interact
biotinyl
tylophorin
total
protein
band
specif
associ
biotinyl
tylophorin
compar
biotinxss
fig
band
excis
matrixassist
laser
desorpt
ionizationtim
flight
malditof
mass
spectrometri
ms
proteom
analys
potenti
tylophorineinteract
protein
identifi
mascot
data
analysi
fig
supplement
tabl
specif
interact
protein
biotinyl
tylophorin
valid
western
blot
analysi
fig
nucleolin
splice
factor
psf
polyadenylatebind
heterogen
nuclear
ribonucleoprotein
hnrnpq
tatabind
proteinassoci
factor
isoform
ribosom
protein
phosphoryl
ribosom
protein
specif
pull
biotinyl
tylophorin
compar
biotinxss
dmso
express
level
protein
tylophorinetr
carcinoma
cell
significantli
alter
compar
dmsotreat
cell
except
significantli
increas
fig
pulldown
ribosom
protein
biotinyl
tylophorin
unexpect
tylocrebrin
previous
report
inhibit
transloc
peptidyltrna
ribosom
although
tylocrebrin
concentr
high
use
tylophorin
compound
exert
signific
anticanc
activ
gener
valu
rang
hundr
nm
examin
protein
identifi
seek
specif
target
anticanc
identifi
among
molecul
pull
biotinyl
tylophorin
focus
protein
ubiquit
express
requir
normal
progress
phase
perform
coimmunoprecipit
use
antibodi
assess
associ
complex
member
identifi
within
complex
presenc
biotinyl
tylophorin
fig
previous
report
associ
coloc
within
rnarich
cytoplasm
granul
dissect
associ
cmyc
mrna
cyclin
mrna
cell
rtpcr
analysi
product
pulldown
experi
biotinyl
tylophorin
fig
also
demonstr
direct
weak
interact
biotinyl
tylophorin
anoth
pulldown
experi
use
purifi
recombin
protein
fig
furthermor
sediment
fraction
reveal
cmyc
mrna
cyclin
mrna
coloc
within
polysom
fraction
upon
tylophorin
treatment
fig
coloc
occur
vehicletr
cell
fig
moreov
low
abund
cyclin
observ
certain
carcinoma
cell
line
fig
certain
condit
loss
specif
cyclin
compens
presenc
other
investig
reveal
cyclin
mrna
coloc
cmyc
mrnaassoci
rnp
complex
fig
well
within
polysom
fraction
fig
result
indic
either
cyclin
mrna
might
sequest
biotinyl
tylophorin
fig
associ
tylophorinetarget
rnp
complex
tylophorinetr
cell
fig
examin
effect
tylophorin
express
cmyc
cyclin
base
pulldown
result
tylophorin
treatment
increas
mrna
level
cmyc
cyclin
cell
cyclin
mrna
level
increas
cell
upon
tylophorin
treatment
sinc
cyclin
mrna
level
undetect
cell
report
regardless
tylophorin
treatment
fig
howev
cmyc
cyclin
protein
level
diminish
cell
upon
tylophorin
treatment
fig
addit
expect
cyclin
protein
level
decreas
tylophorin
treat
cyclin
detect
cell
fig
furthermor
use
tamra
label
newli
synthes
protein
tylophorin
treatment
follow
immunoprecipit
western
blot
detect
protein
interest
found
de
novo
protein
synthes
cmyc
diminish
upon
tylophorin
treatment
protein
fig
cell
deplet
sirna
result
cell
becam
resist
tylophorin
compound
fold
higher
valu
tylophorin
potent
deriv
dbq
fig
accordingli
amount
protein
fig
mrna
cmyc
cyclin
pull
biotinyl
tylophorin
decreas
fig
result
suggest
tylophorin
block
protein
express
cmyc
cyclin
associ
therebi
downregul
downstream
signal
pathway
exert
anticanc
activ
role
tylophorinedownregul
signal
pathway
cmyc
cyclin
anticancer
tylophorin
investig
follow
prb
protein
common
downstream
effector
cyclin
cmyc
examin
tylophorin
effect
anticanc
activ
prb
hypophosphoryl
activ
form
tylophorinetr
carcinoma
cell
wherea
protein
express
level
remain
unchang
fig
result
expect
protein
express
prb
upstream
regul
cyclin
cmyc
reduc
tylophorin
treatment
therebi
decreas
phosphoryl
prb
fig
cyclin
downregul
tylophorin
partial
account
arrest
induc
tylophorin
cyclin
promot
region
contain
two
regulatori
site
either
cyclin
fig
panel
cyclin
fig
panel
overexpress
downstream
hyperphosphoryl
prb
resum
therebi
upregul
cyclin
express
tylophorinetr
cell
fig
moreov
ectop
overexpress
cmyc
also
restor
hyperphosphoryl
downstream
effector
prb
well
cyclin
express
strikingli
express
cyclin
restor
ectop
overexpress
cmyc
fig
even
though
cyclin
downstream
target
gene
cmyc
signal
result
hyperphosphoryl
prb
least
part
attribut
increas
level
cyclin
fig
cmyc
target
anoth
upstream
effector
prb
feedback
upregul
cyclin
ectop
overexpress
cyclin
also
abl
partial
resum
hyperphosphoryl
prb
fig
result
emphas
even
ectop
express
cmyc
upregul
stabil
transcript
cyclin
mrna
subject
sequestr
tylophorin
cmyc
mrnaassoci
rnp
complex
therebi
block
translat
therefor
ectop
express
cmyc
resum
hyperphosphoryl
prb
pathway
independ
cyclin
summari
activ
hypophosphoryl
prb
inactiv
hyperphosphoryl
form
upon
overexpress
cyclin
cmyc
tylophorinetr
carcinoma
cell
hypophosphoryl
prb
play
import
role
facilit
anticanc
activ
tylophorin
accordingli
downstream
pathway
target
cmyc
well
cyclin
eg
prb
cyclin
cyclin
also
downregul
contribut
anticanc
activ
tylophorin
demonstr
function
consequ
cmyc
signal
inhibit
tylophorin
cellular
event
specif
regul
cmyc
warburg
effect
cancer
metabol
format
process
bodi
pbodi
examin
although
tylophorinetr
cell
viabl
prolifer
complet
suppress
signific
apoptosi
occur
therefor
examin
effect
tylophorin
treatment
glutaminas
type
ldha
lactat
dehydrogenas
cmyctarget
gene
mediat
cancer
cell
nutrient
suppli
via
warburg
effect
observ
protein
express
level
gene
downregul
tylophorinetr
carcinoma
cell
fig
cmyc
overexpress
tylophorinetr
cell
protein
express
level
ldha
restor
fig
thu
tylophorin
downregul
warburg
effect
suppress
cmyc
protein
express
level
level
cmyc
target
gene
involv
cytoplasm
mrnp
process
significantli
reduc
carcinoma
cell
level
anoth
constitu
pbodi
fig
next
examin
effect
tylophorin
treatment
pbodi
format
use
confoc
immunofluoresc
microscopi
indic
number
pbodi
popul
cell
exhibit
pbodi
dramat
decreas
upon
tylophorin
treatment
hela
cell
fig
tylophorinerel
alkaloid
potent
inhibit
growth
wide
varieti
drugsensit
drugresist
cancer
cell
line
evalu
cmyc
protein
express
level
panel
carcinoma
cell
line
carcinoma
cell
line
type
tumor
fibroblast
cell
line
tylophorin
treatment
observ
sustain
blockad
cmyc
protein
express
individu
carcinoma
cell
line
upon
treatment
tylophorin
potent
deriv
dbq
fibroblast
cell
line
cmyc
protein
express
level
reduc
fig
wherea
cmyc
mrna
level
increas
fig
also
perform
gene
express
profil
analysi
cmyc
downstream
pathway
affect
tylophorin
dbq
fig
well
valid
rtqpcr
fig
compound
increas
express
cmyc
mrna
mrna
level
gene
upregul
cmyc
decreas
eg
cyclin
cyclin
mrna
level
gene
downregul
cmyc
increas
eg
fig
result
consist
observ
increas
cmyc
mrna
level
decreas
cmyc
protein
level
occur
tylophorinetr
cell
led
neg
regul
cmyc
effector
pathway
gene
whose
express
upregul
downregul
tylophorin
dbq
associ
function
cmyc
carcinogenesi
shown
fig
mous
tumor
model
use
human
lung
carcinoma
xenograft
dbq
significantli
reduc
tumor
volum
dosedepend
manner
final
examin
cmyc
protein
mrna
express
xenograft
tumor
result
confirm
reduct
cmyc
protein
level
concomit
increas
mrna
level
dosedepend
manner
dbq
tumor
compar
vehicletr
tumor
fig
result
correl
vivo
antitumor
activ
vitro
anticanc
result
dbq
fig
studi
found
tylophorin
compound
exert
anticanc
activ
via
target
cmyc
mrna
cyclin
mrna
contain
rnp
complex
inhibit
function
rnp
compon
block
protein
translat
correspond
mrna
transcript
eg
cmyc
cyclin
cyclin
well
downstream
pathway
compon
prb
fig
abnorm
cmyc
signal
cancer
cell
associ
oncogen
downregul
cmyc
tylophorin
compound
might
play
signific
role
anticanc
activ
compound
therapeut
target
rnp
complex
repres
underexplor
emerg
strategi
drug
discoveri
rnp
ribonucleoprotein
rna
protein
molecul
ribosom
enzym
telomeras
hnrnp
small
nuclear
rnp
snrnp
viral
rnp
complex
interact
rnp
complex
exhibit
multipl
role
dynam
conform
chemic
instabl
therefor
target
rnp
discoveri
develop
therapeut
agent
remain
challeng
howev
sever
antivir
agent
report
target
viral
rnp
complex
high
potenc
exhibit
signific
potenti
develop
therapeut
drug
best
knowledg
anticanc
agent
target
rnp
complex
report
first
report
target
rnp
complex
ie
target
cmyc
mrnacontain
rnp
complex
tylophorin
compound
carcinoma
cell
effici
elicit
anticanc
activ
significantli
pulldown
experi
use
biotinyl
tylophorin
reveal
associ
cmyc
mrna
cyclin
mrna
untreat
carcinoma
cell
lysat
fig
mrna
cmyc
cyclin
upregul
observ
tylophorinetr
carcinoma
cell
fig
howev
observ
polysom
coloc
cmyc
mrna
cyclin
mrna
dmsotreat
carcinoma
cell
sediment
fraction
fig
thu
conclud
bind
tylophorin
enhanc
recruit
cmyc
mrna
cyclin
mrna
rnp
complex
hypothesi
also
confirm
associ
cmyc
mrna
cyclin
polysom
fraction
tylophorin
vehicletr
carcinoma
cell
fig
wherea
cmyc
mrna
cyclin
mrna
level
elev
tylophorinetr
carcinoma
cell
fig
increas
mrna
level
cmyc
cyclin
induc
upon
tylophorin
treatment
carcinoma
cell
might
least
partial
reflect
impair
mrna
degrad
due
tylophorin
treatment
consist
dramat
decreas
observ
number
pbodi
suggest
blockad
cellular
mrna
degrad
process
moreov
cytoplasm
mrna
cycl
polysom
pbodi
stress
granul
translat
repress
occur
compart
differ
mechan
addit
tylophorin
treatment
dramat
decreas
format
pbodi
fig
stress
granul
nearli
found
either
dmso
tylophorin
treat
carcinoma
cell
supplement
figur
use
tamra
label
newli
synthes
protein
tylophorin
treatment
clearli
demonstr
tylophorin
repress
protein
express
cmyc
cyclin
fig
result
firm
tylophorin
sequest
rnp
contain
cmyc
mrna
polysom
fraction
fig
block
correspond
mrna
translat
howev
detail
underli
mechan
must
care
address
investig
result
suggest
highli
associ
transport
cmyc
cyclin
cyclin
mrna
translat
thu
abrog
specif
biolog
function
result
induct
cell
cycl
arrest
phase
express
cmyc
elev
numer
tumor
type
result
multipl
mechan
cmyc
accumul
promot
region
activ
gene
carcinoma
cell
lead
abnorm
transcript
amplif
oncogen
therefor
upregul
cmyc
gener
associ
tumor
aggress
poor
clinic
outcom
thu
conceiv
inhibit
cmyc
significantli
contribut
broadspectrum
anticanc
activ
tylophorin
compound
drugresist
carcinoma
cell
moreov
induct
cell
cycl
arrest
knockdown
suggest
addit
cmyc
mrnaassoci
rnp
complex
may
favor
potenti
novel
anticanc
drug
target
ultim
blockad
cmyc
mrna
transport
tylophorinemedi
sequest
cmyc
mrna
cyclin
mrnacontain
rnp
complex
may
contribut
significantli
anticanc
effect
elicit
tylophorin
conjunct
accumul
cjun
fig
tylophorin
enhanc
cjun
downregul
cyclin
promot
activ
result
carcinoma
cell
dominantli
arrest
phase
anticanc
activ
ectop
overexpress
cmyc
affect
accumul
cjun
induc
tylophorin
treatment
increas
express
cyclin
via
hyperphosphoryl
prb
supplement
figur
fig
thu
conclud
elev
cjun
level
tylophorin
function
concert
target
cmyc
mrnacontain
rnp
complex
produc
anticanc
activ
tylophorin
compound
fig
tylophorin
dbq
prepar
describ
puriti
greater
determin
revers
pahsehplc
scheme
synthesi
biotinyl
tylophorin
puriti
analyz
revers
pahsehplc
shown
fig
see
nmr
data
supplement
figur
compound
prepar
previous
describ
react
overnight
mixtur
nah
tertbutyl
carbam
dmf
produc
compound
reduc
compound
ratio
thf
room
temperatur
h
produc
compound
nbocprotect
amin
deprotect
room
temperatur
h
produc
compound
final
biotinxss
invitrogen
coupl
compound
use
dmf
room
temperatur
h
produc
compound
biotinyl
tylophorin
tylophorinebas
dibenzoquinolin
deriv
fig
compound
yellow
crystal
mhz
hz
hz
dd
hz
hz
hz
hz
br
hz
hz
dd
hz
hz
dd
hz
hz
mhz
esim
mz
na
hrm
calcd
found
two
human
fibroblast
cell
line
detroit
atcc
atcc
human
embryon
kidney
cell
line
atcc
human
carcinoma
cell
line
breast
atcc
atcc
bcrc
cervix
hela
bcrc
colon
atcc
atcc
gastric
japanes
cancer
research
resourc
bank
leukemia
atcc
liver
atcc
lung
atcc
obtain
american
type
cultur
collect
cultur
passag
fewer
month
initi
purchas
nasopharyng
gift
dr
chinghwa
tsai
nation
taiwan
univers
taiwan
roc
short
tandem
repeat
str
profil
perform
bioresourc
collect
research
center
bcrc
taiwan
dna
profil
uniqu
match
found
known
str
databas
see
data
supplement
tabl
pancreat
bcrc
prostat
du
atcc
use
studi
hela
detroit
cell
maintain
dulbecco
modifi
eagl
medium
dmem
hyclon
laboratori
inc
supplement
fetal
bovin
serum
fb
hyclon
laboratori
inc
du
cell
maintain
dmemfb
medium
supplement
mm
sodium
pyruv
gibcolif
technolog
cell
cultur
rpmi
medium
gibcolif
technolog
supplement
fb
cell
maintain
rpmi
medium
supplement
mm
sodium
pyruv
silenc
cell
cellswel
cellswel
cellswel
seed
plate
subject
measur
growth
inhibit
tylophorin
biotinlyl
tylophorin
dbq
valu
determin
previous
describ
cell
lysat
incub
biotinyl
tylophorin
h
biotinyl
tylophorineassoci
complex
pull
use
streptavidin
dynabead
invitrogen
h
biotinyl
tylophorinebound
protein
elut
laemmli
buffer
analyz
electrophoresi
gradient
sdspage
gel
wh
cm
cm
visual
silver
stain
amersham
bioscienc
protein
band
interest
excis
subject
ingel
digest
see
supplement
materi
method
analyz
lcmsm
use
thermo
scientif
ltq
xl
mass
spectromet
thermo
scientif
addit
western
blot
use
identifi
protein
compon
pulldown
biotinyl
tylophorinebound
rna
elut
trizol
reagent
invitrogen
rtpcr
use
analyz
associ
compon
previous
describ
procedur
use
mrna
express
level
fig
determin
semirtqpcr
analyz
use
gelpro
analyz
program
normal
use
housekeep
gene
gapdh
necessari
fig
chang
mrna
express
level
determin
use
method
gapdh
housekeep
gene
primer
pair
use
pcr
reaction
list
supplement
tabl
perform
western
blot
previous
describ
antibodi
list
supplement
tabl
see
supplement
materi
method
coimmunoprecipit
use
antibodi
proteintech
group
obtain
origen
transfect
cell
express
purifi
use
antiflag
affin
gel
sigmaaldrich
wash
tb
buffer
human
protein
elut
flag
peptid
nmetasptyrlysasphisaspglyasptyrlysasphisaspileasptyrlysaspaspaspasplysc
sigmaaldrich
cell
treat
cycloheximid
min
harvest
total
cell
lysat
clarifi
centrifug
min
rpm
supernat
load
top
sucros
gradient
ultracentrifug
beckman
rotor
h
rpm
fraction
collect
bottom
tube
absorb
measur
wavelength
nm
use
akta
purifi
ge
healthcar
amersham
bioscienc
rna
protein
extract
use
trizol
reagent
invitrogen
protein
express
mrna
express
analyz
western
immunoblot
analysi
semirtqpcr
respect
cell
wash
pb
cultur
methioninefre
dmem
gibcolif
technolog
h
prior
addit
tylophorin
hpg
lhomopropargylglycin
invitrogen
incub
h
cell
harvest
subject
click
reaction
tamra
tetramethylrhodamin
invitrogen
label
de
novo
synthes
protein
protein
reaction
buffer
accord
manufactur
protocol
invitrogen
result
cell
lysat
immunoprecipit
proteintech
group
anticmyc
cell
signal
technolog
anticyclin
anticyclin
santa
cruz
biotechnolog
antitamra
thermo
scientif
gar
perkinelm
respect
overnight
constant
agit
prior
incub
protein
g
agaros
millipor
anoth
h
wash
specif
immunoprecipit
protein
elut
analyz
western
immunoblot
analysi
antibodi
indic
cell
transfect
shrna
plasmid
origen
scrambl
pgfpcshlenti
shrna
origen
use
fugen
roch
h
post
transfect
cell
cultur
presenc
mgml
puromycin
select
addit
pseudotyp
lentiviru
contain
shrna
clone
id
neg
control
shrna
shlacz
clone
id
academia
sinica
taiwan
transduct
cell
moi
cultur
medium
contain
polybren
millipor
h
post
transduct
cell
cultur
presenc
mgml
puromycin
select
fugen
roch
use
transient
transfect
construct
cell
accord
manufactur
protocol
h
transfect
cell
treat
either
vehicl
control
dmso
tylophorin
addit
h
cell
harvest
lysi
buffer
describ
prior
immunoblot
analys
code
region
human
cyclin
cyclin
cmyc
amplifi
cdna
use
follow
primer
pair
cyclin
cyclin
gcgtcgcacaagagttccgtagct
cmyc
code
region
next
subclon
ecorixhoi
site
pcmvmyc
asisimlui
site
gener
express
vector
human
express
vector
amplifi
mgc
clone
open
biosystem
primer
pair
subclon
ecorixhoi
site
pcmvmyc
clontech
ifa
perform
describ
previous
use
santa
cruz
biotechnolog
antipabp
abcam
antibodi
detect
pbodi
stress
granul
fluoresc
imag
perform
use
leica
tsc
laserscan
confoc
microscop
xenograft
murin
tumor
tissu
flashfrozen
liquid
nitrogen
wash
icecold
pb
homogen
use
tissuelys
ii
qiagen
accord
manufactur
protocol
total
protein
extract
lysi
buffer
detail
analyz
western
blot
total
rna
extract
use
trizol
reagent
invitrogen
revers
transcrib
use
superscript
iii
invitrogen
analyz
realtim
rtqpcr
describ
cell
treat
vehicl
control
dmso
dbq
tylophorin
treatment
compound
h
total
rna
extract
use
trizol
reagent
invitrogen
express
profil
code
gene
perform
use
illumina
human
express
beadchip
furthermor
gene
express
data
illumina
array
valid
realtim
rtqpcr
